Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
IQVIA Holdings, Inc. Common Stock
(NY:
IQV
)
185.19
+3.76 (+2.07%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about IQVIA Holdings, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
Next >
10 Health Care Stocks Whale Activity In Today's Session
March 11, 2025
Via
Benzinga
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
March 11, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Repligen (NASDAQ:RGEN) and...
Via
StockStory
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
March 05, 2025
Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.
Via
StockStory
Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor
February 25, 2025
Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.
Via
Benzinga
Earnings Scheduled For February 6, 2025
February 06, 2025
Via
Benzinga
Analyst Expectations For IQVIA Hldgs's Future
February 03, 2025
Via
Benzinga
How Is The Market Feeling About IQVIA Hldgs?
January 03, 2025
Via
Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
November 20, 2024
Via
Benzinga
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow
February 18, 2025
Lab services company Charles River Laboratories (NYSE:CRL) will be reporting earnings tomorrow before the bell. Here’s what investors should know.
Via
StockStory
West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For
February 12, 2025
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings tomorrow morning. Here’s what to look for.
Via
StockStory
Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect
February 09, 2025
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market hours. Here’s what to expect.
Via
StockStory
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions
February 06, 2025
IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and solid R&DS bookings fuel confidence.
Via
Benzinga
Gapping S&P500 stocks in Thursday's session
February 06, 2025
Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session.
Via
Chartmill
Peering Into IQVIA Hldgs's Recent Short Interest
November 05, 2024
Via
Benzinga
Looking Into IQVIA Hldgs's Recent Short Interest
October 17, 2024
Via
Benzinga
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?
February 06, 2025
It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights
October 08, 2024
Via
Benzinga
How Is The Market Feeling About IQVIA Hldgs?
October 01, 2024
Via
Benzinga
A Closer Look at 13 Analyst Recommendations For IQVIA Hldgs
September 20, 2024
Via
Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
September 10, 2024
Via
Benzinga
Wondering what's happening in today's S&P500 pre-market session?
February 06, 2025
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Via
Chartmill
IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars
February 06, 2025
Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year revenue...
Via
StockStory
IQVIA (IQV) Q4 Earnings Report Preview: What To Look For
February 05, 2025
Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to look for.
Via
StockStory
Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier?
January 14, 2025
Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Elliott Investment Management Adds To Southwest, Western Digital, Etsy, Match Group; Trims BILL Holdings, Seadrill, BlackLine, NRG Energy In Q3
November 14, 2024
Elliott Investment Management was busy in the third quarter. According to a new 13-F filing with the SEC, the activist made several portfolio moves, with multiple new positions focused around travel...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations
October 10, 2024
RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age group and reducing demand by two-thirds compared to last year.
Via
Benzinga
Four Stocks To Watch This Week - Tuesday, Oct. 01
October 01, 2024
A flat week that was anticipated, one notable event was China's stimulus package announcement, which sent China-related stocks soaring. Most of these stocks surged without prior consolidations/warning...
Via
Talk Markets
Is Viking Therapeutics Stock a Buy?
September 29, 2024
The company is in the spotlight for one of its programs, but it's got others that also have promise.
Via
The Motley Fool
Cloud Stocks: Salesforce Preps To Enter Veeva’s Territory
September 14, 2024
Veeva Systems recently announced its quarterly results that continued to impress the market. Vault CRM continues to remain the buzz word for Veeva as Salesforce gears up for more direct competition...
Via
Talk Markets
Contract Research Giant IQVIA's Data Assets Are Biggest Differentiator, Provides Best Exposure To AI And Data Opportunities: Analyst
September 04, 2024
RBC Capital Markets has initiated coverage on IQVIA highlighting the company's extensive data assets as its key differentiator. It has faced challenges in investor sentiment and EPS growth due to the...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.